The company
ICON plc -
ICLR · Nasdaq
ICLR stood above a rising 150-day average in 17 of the last 52 weekly readings, including each of the last 4 weeks. It is 16.9% above that average now. Life Science Tools & Research Services: 52% of its 79 stocks in an uptrend (+4 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- In trend
- Weeks in an uptrend
- 4 in a row
- Industry in uptrend
- 52% +4 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $8.1M
- Officials’ trades on record
- 20
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 17 of 52 weeks.
Life-science tools: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars. Not yet read: institutions.
Congress and officials
20 disclosed lines: House 17, Senate 0, executive 3; 8 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Kevin Hern House: U.S. House ClerkOK01 | soldjoint | $15k–$50k | 14 Aug 2026filed 1 Sep 2026 |
| Kevin Hern House: U.S. House ClerkOK01 | soldjoint | $100k–$250k | 5 Mar 2026filed 3 Apr 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 19 Feb 2026filed 14 May 2026 |
| Julia Letlow House: U.S. House ClerkLA05 | sold | $1k–$15k | 12 Feb 2026filed 12 Mar 2026 |
| Stephen I. Miran Executive branch: Office of Government EthicsCouncil of Economic Advisers | sold | $15k–$50k | 9 Jun 2025filed 6 Sep 2025 |
| John James House: U.S. House ClerkMI10 | sold | $1k–$15k | 4 Sep 2024filed 6 Sep 2024 |
| John James House: U.S. House ClerkMI10 | bought | $1k–$15k | 12 Jun 2024filed 2 Sep 2024 |
| Nuria Fernandez Executive branch: Office of Government EthicsDepartment of Transportation | bought | $1k–$15k | 15 Aug 2023filed 26 Oct 2023 |
| Kevin Hern House: U.S. House ClerkOK01 | soldjoint | $1k–$15k | 31 Jan 2023filed 14 Feb 2023 |
| Kevin Hern House: U.S. House ClerkOK01 | bought | $15k–$50k | 2 Sep 2021filed 7 Oct 2021 |
| Kevin Hern House: U.S. House ClerkOK01 | bought | $100k–$250k | 18 May 2021filed 15 Jun 2021 |
| Kevin Hern House: U.S. House ClerkOK01 | boughtjoint | $1k–$15k | 27 Jul 2020filed 15 Aug 2020 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Ronan Martin MurphyDirector | sold | 5,005at $175.00 | 17 Sep 2026filed 18 Sep 2026 |
| Eugene Pacelli McCagueDirector | sold | 3,255at $175.00 | 17 Sep 2026filed 18 Sep 2026 |
| John ClimaxDirector | sold | 5,005at $175.00 | 16 Sep 2026filed 18 Sep 2026 |
| Nigel Bernard John ClerkinChief Financial Officer | sold | 237at $162.72 | 11 Aug 2026filed 12 Aug 2026 |
| Nigel Bernard John ClerkinChief Financial Officer | sold | 259at $163.77 | 11 Aug 2026filed 12 Aug 2026 |
| Nigel Bernard John ClerkinChief Financial Officer | sold | 1,591at $164.47 | 11 Aug 2026filed 12 Aug 2026 |
| Nigel Bernard John ClerkinChief Financial Officer | sold | 180at $165.51 | 11 Aug 2026filed 12 Aug 2026 |
| John ClimaxDirector | sold | 88at $162.72 | 11 Aug 2026filed 12 Aug 2026 |
| John ClimaxDirector | sold | 95at $163.77 | 11 Aug 2026filed 12 Aug 2026 |
| John ClimaxDirector | sold | 591at $164.47 | 11 Aug 2026filed 12 Aug 2026 |
| John ClimaxDirector | sold | 67at $165.51 | 11 Aug 2026filed 12 Aug 2026 |
| Linda GraisDirector | sold | 87at $162.72 | 11 Aug 2026filed 12 Aug 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Still reading this part; it fills in a moment.
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.